Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Jirui Pharmaceutical Co., Ltd., commonly known as Jirui Pharmaceutical Factory, is a prominent pharmaceutical manufacturing company based in Nanjing, China. It operates as a core production subsidiary of Simcere Pharmaceutical Group, one of China's leading pharmaceutical companies. The facility specializes in the large-scale manufacturing of small molecule drugs, including both innovative medicines and high-quality generics. Jirui is particularly recognized for producing Simcere's flagship products in the fields of neurology and anti-infectives, such as Edaravone. The company maintains advanced manufacturing lines for injectable and oral dosage forms that comply with international Good Manufacturing Practice (GMP) standards. As a key pillar of Simcere's supply chain, Jirui supports the group's mission to provide effective treatments for oncology, central nervous system disorders, and infectious diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jirui Pharmaceutical Factory.